UBS Group
SAVAW

UBS Group’s Cassava Sciences, Inc. Warrant SAVAW Stock Holding History

UBS Group’s Portfolio SAVAW Stock Details SAVAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,880
Closed -$51.9K – 10410
2024
Q1 		$51.9K Buy
+12,880
New +$76.9K ﹤0.01% 6490

Other funds holding SAVAW

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's SAVAW Position: Q2 2024 in Review

UBS Group sold out of Cassava Sciences, Inc. Warrant (SAVAW) in Q2 2024, closing a stake of 12,880 shares — an estimated $51.9K sold.

UBS Group first reported a position in SAVAW in Q1 2024 and held it in 1 quarter. The position peaked at $51.9K in Q1 2024. 3 funds tracked by Wall St. Rank hold SAVAW as of Q2 2024.

  • UBS Group reported no remaining Cassava Sciences, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
  • UBS Group sold 12,880 Cassava Sciences, Inc. Warrant shares in Q2 2024, an estimated $51.9K.
  • UBS Group first reported a position in Cassava Sciences, Inc. Warrant in Q1 2024 and held it in 1 quarter.
  • UBS Group's Cassava Sciences, Inc. Warrant position peaked at $51.9K in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Cassava Sciences, Inc. Warrant as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.